$0.5193
-0.0442-7.84%
Últ. Act.: Oct 23, 7:38 PM
Outlook Therapeutics (OTLK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.12 | $-0.17 | $-0.24 |
| Actual | $-0.09 | $-0.16 | $-0.22 | $-0.19 |
| Surprise | -12.5% | -33.3% | -29.4% | +20.8% |
| Revenue | ||||
| Estimate | $1.0M | $4.4M | $3.4M | $6.0M |
| Actual | $9000 | $128000 | $-1.2M | $-91787 |
| Surprise | -99.1% | -97.1% | -135.3% | -101.5% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.05 | $-0.04 | $-0.03 |
| Revenue | ||||
| Consensus | $2.4M | $5.6M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $-0.09 | $-0.08 | -12.5 % |
| Q2 | May 15, 2026 | $-0.16 | $-0.12 | -33.3 % |
| Q1 | Feb 17, 2026 | $-0.22 | $-0.17 | -29.4 % |
| Q4 | Dec 19, 2025 | $-0.19 | $-0.24 | 20.8 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 14, 2026 | $9.00K | $1.01M | -99.1 % |
| Q2 | May 15, 2026 | $128.00K | $4.40M | -97.1 % |
| Q1 | Feb 17, 2026 | $-1.21M | $3.42M | -135.3 % |
| Q4 | Dec 19, 2025 | $-91.79K | $5.96M | -101.5 % |